1.苏州大学附属第一医院, a. 药学部,b. 临床营养科, c. 肾内科, 江苏 苏州 215006; 2.贵阳市妇幼保健院药剂科, 贵阳 550003
Practice of Multidisciplinary Outpatient Service in the Department of Nephrology Participated by the Clinical Pharmacist
YU Wen-liu1a, LIU Xing-xing2, LU Ruo-lin1b, LIU Xue1c, SHEN Lei1c, HANG Yong-fu1a*
1a. Department of Pharmacy, 1b. Department of Clinical Nutrition, 1c. Department of Nephrology, The First Affiliated Hospital of Soochow University, Suzhou 215006,China; 2. Department of Pharmacy, Guiyang Maternal and Child Health Care Hospital, Guiyang 550003, China
Abstract:OBJECTIVE To investigate the mode of multidisciplinary outpatient service in the department of nephrology participated by the clinical pharmacist. METHODS The treatment team consist of clinical pharmacist, clinician, nurse and nutritionist in the department of nephrology provides comprehensive treatment for patients with chronic kidney disease (CKD). Clinical pharmacist filled the CKD patients records who visited the outpatient department of nephrology from January 2018 to July 2019 including basic information, disease diagnosis, drug compliance evaluation and medication reconciliation. The PCNE classification (Version 9.00) was used to assess and intervene in the CKD patients drug related problems (DRPs) and statistical analysis of results. RESULTS According to the exclusion criteria, 88 cases and 62 patients were included in this study. 3 patients (4.84%) had stage 2 CKD, 43 patients (69.35%) had stage 3 CKD, 11 patients (17.74%) had stage 4 CKD, 5 patients (8.06%) had stage 5 CKD. 41 patients (66.13%) had hypertension, 30 patients (48.39%) had hyperuricemia, 14 patients (22.58%) had hyperlipidemia, 10 patients (16.13%) had diabetes mellitus, 9 patients (14.52%) had anemia. The average number of drugs used per patient was (6.11±2.44) species (1-13 species) and 47 patients (75.81%) took more than five species drugs. Ninty-three medication-related problems were found, distribution of harmed levels as follows: 29 problems (31.18%) were level C, 27 problems (29.03%) were level D, 25 problems (26.88%) were level A, 11 problems (11.83%) were level E, only one problem (1.08%) was level B. All of them were fully implemented by intervention, compliance score of 86.67% of subsequent visit patients were attached 8. CONCLUSION Through the intervention of clinical pharmacist to the patients with CKD, the compliance of patients can be improved, and DRPs can be reduced to ensure the efficacy and safety of drugs.
郁文刘, 刘星星, 陆若琳, 刘雪, 沈蕾, 杭永付. 临床药师参与肾内科联合门诊服务工作的实践[J]. 中国药学杂志, 2020, 55(23): 1969-1973.
YU Wen-liu, LIU Xing-xing, LU Ruo-lin, LIU Xue, SHEN Lei, HANG Yong-fu. Practice of Multidisciplinary Outpatient Service in the Department of Nephrology Participated by the Clinical Pharmacist. Chinese Pharmaceutical Journal, 2020, 55(23): 1969-1973.
LIU X Q, CHEN Y. Research progress of nutritional management for patients with chronic renal disease[J]. Nur Integr Tradit Chin West Med(中西医结合护理), 2019,5(5):229-232.
[2]
YANG J, LIU Y, ZHANG M, et al. Exploration of entry points of traditional Chinese clinical pharmacists participating in multi-disciplinary team[J]. China Pharm(中国药师),2018,21(10):1783-1786.
[3]
HO C P, LEE T J F. The reliability and validity of the Chinese version of the eight-item Morisky medication adherence scale[J]. Value in Health, 2014, 17(7): A730.
[4]
FOUNDATION, PCNE. PCNE Classification for drug related problems V9.0. [EB/OL]. [2019-07-30]. https://www.pcne.org/upload/files/334_PCNE_classification_V9.0.pdf.
[5]
MEDICATION SAFETY PANEL IN CHINA CORE GROUP OF INTERNATIONAL NET WORK FOR THE RATIONAL USE OF DRUGS(INRUD), CHINESE PHARMACO1OGICAL SOCIETY PROFESSIONAL COMMITTEE OF DRUG INDUCED-DISEASES, CHINESE PHARMACEUTICAL ASSOCIATION PROFESSIONAL COMMITTEE OF HOSPITAL PHARMACY, et al. Expert consensus on medication error management in China[J]. Adverse Drug React J(药物不良反应杂志),2014,16(6):321-326.
[6]
NATIONAL COORDINATING COUNCIL FOR MEDICATION ERROR REPORTING AND PREVENTION. About Medication Errors[EB/OL]. [2020-06-01]. http://www.nccmerp.org/aboutMedError.html.
[7]
HAO R,HANG Y F, LIU X X, et al. Development of medication reconciliation model for chronic kidney disease in our hospital[J]. Chin Pharm J(中国药学杂志),2020,55(5):408-413.
[8]
WANG H X, ZHU X T, XIE C, et al. Primary medication reconciliation service provided by clinical pharmacist for chronic kidney disease in our hospital[J]. Chin Pharm J(中国药学杂志), 2018, 53(24):2148-2151.
[9]
ZHU X T, HANG Y F. Clinical pharmacists' pharmaceutical care and practice in the department of nephrology[J]. Chin J Clin Pharmacol Ther(中国临床药理学与治疗学),2018,23(10):1174-1178.
[10]
WANG H X, HANG Y F. Pharmaceutical services in the department of nephrology: examples and experiences[J]. Cent South Pharm(中南药学),2019,17(4):607-609.